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Whereas astrocytes have been in the limelight of scientific interest in brain energy metabo-
lism for a while, oligodendrocytes are still waiting for a place on the metabolic stage. We
propose to term the interaction of oligodendrocytes with astrocytes and neurons: NOA
(neuron–oligodendrocyte–astrocyte) interactions. One of the reasons to find out more
about metabolic interactions between oligodendrocytes, neurons, and astrocytes is to
establish markers of healthy oligodendrocyte metabolism that could be used for the diag-
nosis and assessment of white matter disease. The vesicular release of glutamate in the
white matter has received considerable attention in the past. Oligodendrocyte lineage
cells express glutamate receptors and glutamate toxicity has been implicated in diseases
affecting oligodendrocytes such as hypoxic-ischaemic encephalopathy, inflammatory dis-
eases and trauma. As oligodendrocyte precursor cells vividly react to injury it is also
important to establish whether cells recruited into damaged areas are able to regener-
ate lost myelin sheaths or whether astrocytic scarring occurs. It is therefore important to
consider metabolic aspects of astrocytes and oligodendrocytes separately. The present
review summarizes the limited evidence available on metabolic cycles in oligodendrocytes
and so hopes to stimulate further research interests in this important field.
Keywords: energy metabolism, glucose, gray matter, white matter, pyruvate carboxylation, glycolysis, lactate,
monocarboxylate transporters
INTRODUCTION
The body of research from the last century has established the
present view of contiguous neurons in continuous, dynamic inter-
action with several types of glial cells (astrocytes, oligodendro-
cytes, microglia). The interactions between neurons and astrocytes
characterized by the glutamate–glutamine(–GABA) shuttle have
received considerable attention since its discovery in the 1970s (van
den Berg and Garfinkel, 1971). This shuttle is necessary since neu-
rons cannot make their amino acid neurotransmitters glutamate
(excitatory, 90% of synapses), GABA (most abundant inhibitory),
and aspartate without glutamine from astrocytes. In this interplay,
glucose has a central role as the major (or exclusive) source of
energy for the adult brain and the molecules used to synthesize
glutamine and thus glutamate, GABA, and aspartate (McKenna
et al., 2011).
In gray matter, glutamate released from neurons in glutamater-
gic neurotransmission is mainly taken up by astrocytes (Gege-
lashvili and Schousboe, 1997, 1998). This drain of glutamate is
compensated for by a flow of glutamine from astrocytes to neu-
rons, thus closing the glutamate–glutamine cycle (Figure 1). Net
synthesis of tricarboxylic acid (TCA) cycle intermediates and
related compounds like glutamate and glutamine depend upon
entry of pyruvate via an anaplerotic pathway into the TCA cycle.
In the brain, this is preferentially or exclusively achieved by pyru-
vate carboxylase (Patel, 1974a; Waagepetersen et al., 2001), which
is not present in neurons but has been shown to be present in
astrocytes (Yu et al., 1983; Shank et al., 1985; Cesar and Hamprecht,
1995). This process generates a “new” molecule of oxaloacetate,
which may condense with acetyl-CoA to provide net synthesis of
the TCA cycle intermediateα-ketoglutarate, from which glutamate
can be formed by transamination (Westergaard et al., 1996). Subse-
quently, glutamine may be synthesized from glutamate (Figure 1)
via glutamine synthetase, which like pyruvate carboxylase is exclu-
sively expressed in astrocytes (Martinez-Hernandez et al., 1977;
Norenberg and Martinez-Hernandez, 1979). Glutamine released
by astrocytes can also function as precursor for the inhibitory
neurotransmitter GABA via glutamate (Reubi et al., 1978; Son-
newald et al., 1993). Thus, the concept has been extended to a
glutamate–glutamine(–GABA) cycle. The present review aims to
further extend these cycles to include oligodendrocytes. There is
a clear need for exploring the metabolism of oligodendrocytes in
the context of inter-cellular interactions in the brain, involving the
major neural cell types, neurons, astrocytes, and oligodendrocytes.
TRI-CELLULAR COMPARTMENTATION OF BRAIN METABOLISM
Can the bi-cellular compartmentation of the central nervous sys-
tem (CNS) described above be extended to a tri-cellular one
including oligodendrocytes? The lack of knowledge available on
the metabolic role of oligodendrocytes in the brain was high-
lighted recently with two publications in Nature (Funfschilling
et al., 2012; Lee et al., 2012). These studies proposed, for the first
time, a link between glycolytic metabolism in oligodendrocytes
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FIGURE 1 | Schematic overview of the metabolic interactions between
neurons–oligodendrocytes–astrocytes (NOA) discussed in this review.
Glucose (GLC) from the blood is taken up by neurons, astrocytes, and
oligodendrocytes and can be metabolized via glycolysis, giving rise to
pyruvate (PYR). In astrocytes, GLC can also be stored in the form of glycogen.
PYR, the end product of glycolysis can be reduced to lactate (LAC) which can
be released and taken up by cells with lower lactate concentration, be
converted into alanine (not shown) or be converted into acetyl-CoA (Ac-CoA)
and subsequently oxidized in the tricarboxylic acid (TCA) cycle. After synaptic
release of glutamate (GLU) by neurons, astrocytes are responsible for most of
its uptake via specific high-affinity glutamate transporters to prevent neuronal
excitotoxicity, although some pre-synaptic re-uptake can also occur. GLU
taken up by astrocytes can be converted to glutamine (GLN) by glutamine
synthetase (GS) which can be transferred to neurons where it is transformed
into GLU, making it available again for neurotransmission and, in this way,
closing the GLU-GLN cycle. The close association between GLU, GLN, and
TCA cycle metabolism is indicated in the three cell compartments: GLU can
be additionally converted into α-ketoglutarate (α-KG) and be subsequently
oxidized. Even though there are reports on the absence of glutamine
synthetase and pyruvate carboxylase (PC) in oligodendrocytes, it is not totally
clear whether or not they are capable of synthesizing GLN and performing
anaplerosis. Finally, neurons are known to synthesize N -acetyl-aspartate
(NAA) from aspartate (ASP) and Ac-CoA. NAA is thought to be transferred to
oligodendrocytes where it is metabolized into ASP and acetate. Whereas the
resulting acetate is thought to be extensively used for the synthesis of myelin
lipids, the fate of the ASP is still unresolved since it can either be metabolized
in oligodendrocytes or transported back to neurons, closing another
potentially important metabolic cycle in the brain.
and axonal integrity and function. Analysis of hexokinase levels in
the oligodendroglial fractions isolated from rat brain has shown
that in comparison with whole brain or with isolated neurons
or astrocytes, oligodendroglia express low levels of this enzyme
(Snyder and Wilson, 1983). In agreement with this, Rinholm et al.
(2011) suggest that lactate is transported from neurons to oligo-
dendrocytes. Analyzing cell bodies and processes aligned with
axons, which were presumed to be oligodendrocytes, a decrease
in pH was shown when lactate was applied, thus suggesting that
lactate was transported into the cells via MCTs that co-transported
H+. In a mouse model of globoid cell leukodystrophy (Krabbe
disease) an increase in MCT1 was observed in the spinal cord
(Meisingset et al., 2013). It should be noted that MCT1 is not
only expressed by oligodendrocytes, and that its inhibition in
brain has previously been associated with memory deficits due
to astrocytic dysfunction (Suzuki et al., 2011). In the white mat-
ter, astrocytes are located close to oligodendrocytes and may have
different tasks when compared to gray matter astrocytes which are
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predominantly located near neurons. Disruption of white mat-
ter astrocyte–oligodendrocyte–neuronal interaction in multiple
sclerosis is described in Cambron et al. (2012).
TRI-CELLULAR COMPARTMENTATION OF NAA METABOLISM
Several reviews suggest that metabolism of N -acetyl-aspartate
(NAA) has a tri-cellular compartmentation (Baslow, 2000; Mof-
fett et al., 2007). Aspartate needed for NAA production can only
be synthesized de novo in astrocytes (transported to neurons in
the form of glutamine), NAA is then assembled and released from
neurons and hydrolyzed to acetate and aspartate (Figure 1) by
aspartoacylase, which is predominantly located in oligodendroglia
(Madhavarao et al., 2004). Leukodystrophies are characterized
by degeneration of myelin in the phospholipid layer insulating
the axon of a neuron. Canavan’s disease is characterized by an
aspartoacylase deficiency and thus accumulation of NAA (Janson
et al., 2006). Impairment of oligodendrocyte metabolism leading
to accumulation of NAA was also shown in the spinal cord of
Twi mice on postnatal day 30 (Meisingset et al., 2013). However,
NAA production has also been reported in adult oligodendrocytes,
depending on the culturing conditions (Bhakoo and Pearce, 2000).
These authors suggest that mature oligodendrocytes in the adult
brain synthesize NAA in vivo. However, at present there is a lack
of consensus regarding oligodendrocyte-mediated NAA synthesis.
This controversy needs to be resolved as it has important implica-
tions for the interpretation of 1HMRS data since NAA levels are
commonly used as an indicator of neuronal viability.
WHITE AND GRAY MATTER HAVE DIFFERENT ENERGY DEMANDS
There is a distinctive difference between white and gray mat-
ter astrocytes, moreover, the number of neurons and oligoden-
drocytes differs considerably between white and gray matter.
From these observations it follows that energy demands will vary
between these areas. The difference between white and gray mat-
ter metabolic intensity has attracted substantial interest. Most
authors studying these differences agree that CNS white mat-
ter has a lower metabolic intensity than gray matter (Sokoloff,
1977). However, the values published for the cerebral metabolic
rate of glucose (CMRglc) calculated from 2-deoxyglucose uptake
or cytochrome oxidase activity measurements so far reported
differ considerably. Using 2-deoxyglucose uptake in cortex CMR-
glc is 1–1.6µmol (g min)−1 whereas in white matter it is 0.3–
0.4µmol (g min)−1 (references in McKenna et al., 2011). Apply-
ing cytochrome oxidase activity measurements to assess brain
energy consumption it was proposed that the patterns found in
the white matter were similar to those of 2-deoxyglucose uptake
in conscious, “resting” animals, although some differences were
detected (Hevner et al., 1995). For example, 2-deoxyglucose uptake
was found to be approximately threefold higher in gray ver-
sus white matter (Sokoloff, 1977) whereas cytochrome oxidase
activity showed an 8- to 12-fold difference. These and other dis-
crepancies probably reflect basic technical differences between the
two methods used. Compared to 2-deoxyglucose metabolism, the
metabolism of cytochrome oxidase is more specific for oxida-
tive metabolism and less so for glycolysis, and more reflective of
overall neuronal functional activity occurring over longer time
periods lasting hours and weeks, rather than minutes. Measuring
oxygen uptake ratios in brain slices, the levels detected were in
between those reported above (Hertz and Clausen, 1963). A dis-
parity between glycolysis and oxidative metabolism of glucose in
white matter has been found by (Morland et al., 2007). How-
ever, the usefulness of ratios is limited since they do not distin-
guish between axons and non-neuronal cells (oligodendrocytes
and astrocytes). Glucose oxidation has been measured in neu-
rons, astrocytes, and oligodendrocytes from the developing brain
and these measurements showed that oligodendrocytes oxidized
twice as much glucose per hour and mg protein as astrocytes in
the TCA cycle and had only slightly less oxidation than neurons
(Edmond et al., 1987). In this context it should be mentioned
that oligodendrocytes are particularly sensitive to the effects of
energy depletion as shown in case reports on patients exposed to
CO poisoning (Grunnet and Petajan, 1976; Foncin and Le Beau,
1978; Egan et al., 2004). For example, Foncin and Le Beau (1978)
reported an ultrastructural study of biopsy tissue, which showed
well preserved and nearly normal cortex morphology, but exten-
sive white matter injury, with disrupted or degenerated myelin
and pycnotic oligodendroglia due to CO poisoning. In contrast,
the appearance of axons, astrocytes, and capillaries had a nearly
unchanged appearance. The destruction affecting oligodendroglia
may have been caused by a special vulnerability of oligodendro-
cytes to glutamate. Similarly in the neonate, glutamate toxicity
from hypoxia-ischemia during the perinatal period caused white
matter injury and long-term motor and intellectual disability
(Fields, 2010).
THE OPERATION OF SEVERAL METABOLIC PATHWAYS REMAINS
ELUSIVE IN OLIGODENDROCYTES
Another important question is whether oligodendrocytes also
require glutamine from astrocytes. Can oligodendrocytes synthe-
size glutamine? Glutamine is thought to be an important com-
ponent of proteins and an excellent energy substrate. Evidence
suggests that glutamine synthetase is not present in oligoden-
drocytes (Pilkington and Lantos, 1982; Derouiche, 2004). Thus,
it must be assumed that glutamine from astrocytes reaches the
oligodendrocytes, possibly by passing through neurons.
Furthermore, neurons might supply glutamate to the oligoden-
drocytes or oligodendrocytes might regulate glutamate concentra-
tion in extracellular space of the white matter. Glutamate uptake
has been shown in oligodendrocytes in the developing brain, but
not the adult (DeSilva et al., 2009). Moreover, glutamate receptors
are expressed in oligodendrocytes (Karadottir et al., 2005) and
also vesicular glutamate release in the white matter has received
considerable attention (Karadottir et al., 2005; Kukley et al., 2007;
Ziskin et al., 2007).
Do oligodendrocytes express pyruvate carboxylase or are they
dependent on aspartate from neurons (via NAA) for the syn-
thesis of oxaloacetate? Aspartate is an essential member of the
malate aspartate shuttle which is the major shuttle for reducing
equivalents from NADH from glycolysis into the mitochondria
(McKenna et al., 2006). It is important to note that aspartate pro-
duction in neurons is only possible with the help of glutamine
from astrocytes (see above). Acetyl-CoA from NAA degradation
is used for lipid synthesis in oligodendrocytes and possibly energy
production via TCA cycle activity (Figure 1). However, the fate of
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aspartate from NAA is unclear. It might be (a) metabolized in the
TCA cycle in oligodendrocytes, (b) sent back to neurons, or (c)
degraded in both cell types (Figure 1). A pivotal question in this
context is the localization of pyruvate carboxylase. This enzyme is
a nuclear encoded homotetramer found in most eukaryotic and
in many prokaryotic tissues and is a member of the family of
biotin-dependent carboxylases (Wallace et al., 1998).
It is important to establish whether oligodendrocytes have the
possibility to carboxylate pyruvate: if oligodendrocytes express
PC they can afford to return aspartate from NAA to the neu-
rons, if they do not, they cannot afford to do so since PC is the
only anaplerotic enzyme in the brain (Patel, 1974b). There are
a number of publications which propose that PC is exclusively
expressed by astrocytes in the CNS (Yu et al., 1983; Shank et al.,
1985; Kurz et al., 1993; Cesar and Hamprecht, 1995; McKenna
et al., 1995, 2000; Vogel et al., 1998a,b). There is one report
that has identified expression of PC in oligodendrocytes (Murin
et al., 2009). However, the information in this publication has
to be taken with caution since the oligodendrocyte cultures con-
tained 10% astrocytes (Hirrlinger et al., 2002). Evidence for the
lack of PC in oligodendrocytes comes from the lack of glycogen
phosphorylase in those cells (Richter et al., 1996) since glycogenol-
ysis is a prerequisite for glutamate formation (Gibbs et al., 2007;
Sickmann et al., 2012; Xu et al., 2013) probably via dependency
of glutamatergic signaling on pyruvate carboxylase (Hertz et al.,
2013). Another unresolved question concerning oligodendrocytes
is the extent of the pentose phosphate pathway activity. This glu-
cose shunt is active in neurons and astrocytes (Kim et al., 2005;
Brekke et al., 2012) and has its highest activity in oligodendrocytes
in the developing brain (Edmond et al., 1987) but its activity in
mature oligodendrocytes has yet to be investigated. Sykes et al.
(1986) suggest that de novo synthesis of fatty acids and cho-
lesterol by oligodendrocytes of neonatal rats should be closely
geared to the activity of the pentose phosphate pathway in these
cells.
CONCLUSION
From the limited literature available it can be concluded that vital
information about the metabolic capabilities of oligodendrocytes
is still missing. With this review we would like to challenge the sci-
entific community to devote time and effort to unraveling what we
would like to call oligodendrocyte interaction with astrocytes and
neurons (NOA:neuron–oligodendrocyte–astrocyte) interactions.
Well-designed experiments are necessary to find answers to these
and other questions concerning the referred metabolic pathways
and cycles in oligodendrocytes.
REFERENCES
Baslow, M. H. (2000). Functions of
N-acetyl-L-aspartate and N-acetyl-
L-aspartylglutamate in the verte-
brate brain: role in glial cell-
specific signaling. J. Neurochem. 75,
453–459.
Bhakoo, K. K., and Pearce, D. (2000).
In vitro expression of N-acetyl
aspartate by oligodendrocytes:
implications for proton magnetic
resonance spectroscopy signal
in vivo. J. Neurochem. 74, 254–262.
Brekke, E. M., Walls, A. B., Schous-
boe, A., Waagepetersen, H. S., and
Sonnewald, U. (2012). Quantitative
importance of the pentose phos-
phate pathway determined by incor-
poration of 13C from [2-13C]-
and [3-13C]glucose into TCA cycle
intermediates and neurotransmitter
amino acids in functionally intact
neurons. J. Cereb. Blood Flow Metab.
32, 1788–1799.
Cambron, M., D’Haeseleer, M., Laureys,
G., Clinckers, R., Debruyne, J., and
De Keyser, J. (2012). White-matter
astrocytes, axonal energy metabo-
lism, and axonal degeneration in
multiple sclerosis. J. Cereb. Blood
Flow Metab. 32, 413–424.
Cesar, M., and Hamprecht, B. (1995).
Immunocytochemical examination
of neural rat and mouse pri-
mary cultures using monoclonal
antibodies raised against pyru-
vate carboxylase. J. Neurochem. 64,
2312–2318.
Derouiche, A. (2004). “The perisynaptic
astrocyte process as a glial compart-
ment – immunolabelling for glu-
tamine synthetase and other glial
markers,” in Non-Neuronal Cells of
the Nervous System, Function and
Dysfunction, ed. L. Hertz (Amster-
dam: Elsevier), 147–163.
DeSilva, T. M., Kabakov, A. Y., Gold-
hoff, P. E., Volpe, J. J., and Rosen-
berg, P. A. (2009). Regulation of
glutamate transport in developing
rat oligodendrocytes. J. Neurosci. 29,
7898–7908.
Edmond, J., Robbins, R. A., Bergstrom,
J. D., Cole, R. A., and De Vellis, J.
(1987). Capacity for substrate uti-
lization in oxidative metabolism by
neurons, astrocytes, and oligoden-
drocytes from developing brain in
primary culture. J. Neurosci. Res. 18,
551–561.
Egan, P. J., Becker, F. W., and Schumm,
F. (2004). Spongiform leucoen-
cephalopathy after inhaling illicit
heroin and due to carbon monoxide-
intoxication. Fortschr. Neurol. Psy-
chiatr. 72, 26–35.
Fields, R. D. (2010). Glutamate recep-
tors: the cause or cure in perina-
tal white matter injury? Neuron Glia
Biol. 6, 209–211.
Foncin, J. F., and Le Beau, J. (1978).
Myelinopathy due to carbon
monoxyde poisoning. A study in
ultrastructural neuropathology
(author’s transl). Acta Neuropathol.
43, 153–159.
Funfschilling, U., Supplie, L. M., Mahad,
D., Boretius, S., Saab, A. S., Edgar,
J., et al. (2012). Glycolytic oligoden-
drocytes maintain myelin and long-
term axonal integrity. Nature 485,
517–521.
Gegelashvili, G., and Schousboe, A.
(1997). High affinity glutamate
transporters: regulation of expres-
sion and activity. Mol. Pharmacol.
52, 6–15.
Gegelashvili, G., and Schousboe, A.
(1998). Cellular distribution and
kinetic properties of high-affinity
glutamate transporters. Brain Res.
Bull. 45, 233–238.
Gibbs, M. E., Lloyd, H. G., Santa, T.,
and Hertz, L. (2007). Glycogen is a
preferred glutamate precursor dur-
ing learning in 1-day-old chick: bio-
chemical and behavioral evidence. J.
Neurosci. Res. 85, 3326–3333.
Grunnet, M. L., and Petajan, J. H.
(1976). Carbon monoxide-induced
neuropathy in the rat. Ultrastruc-
tural changes. Arch. Neurol. 33,
158–163.
Hertz, L., and Clausen, T. (1963). Effects
of potassium and sodium on respi-
ration: their specificity to slices from
certain brain regions. Biochem. J. 89,
526–533.
Hertz, L., Xu, J., Song, D., Du, T.,
Yan, E., and Peng, L. (2013).
Brain glycogenolysis, adreno-
ceptors, pyruvate carboxylase,
Na(+),K(+)-ATPase and Marie
E. Gibbs’ pioneering learning
studies. Front. Integr. Neurosci. 7:20.
doi:10.3389/fnint.2013.00020
Hevner, R. F., Liu, S., and Wong-Riley,
M. T. (1995). A metabolic map
of cytochrome oxidase in the rat
brain: histochemical, densitomet-
ric and biochemical studies. Neuro-
science 65, 313–342.
Hirrlinger, J., Resch, A., Gutterer, J. M.,
and Dringen, R. (2002). Oligoden-
droglial cells in culture effectively
dispose of exogenous hydrogen per-
oxide: comparison with cultured
neurones, astroglial and microglial
cells. J. Neurochem. 82, 635–644.
Janson, C. G., McPhee, S. W., Francis, J.,
Shera, D., Assadi, M., Freese, A., et
al. (2006). Natural history of Cana-
van disease revealed by proton mag-
netic resonance spectroscopy (1H-
MRS) and diffusion-weighted MRI.
Neuropediatrics 37, 209–221.
Karadottir, R., Cavelier, P., Bergersen, L.
H., and Attwell, D. (2005). NMDA
receptors are expressed in oligoden-
drocytes and activated in ischaemia.
Nature 438, 1162–1166.
Kim, E. J., Park, Y. G., Baik, E. J.,
Jung, S. J., Won, R., Nahm, T.
S., et al. (2005). Dehydroascorbic
acid prevents oxidative cell death
through a glutathione pathway in
primary astrocytes. J. Neurosci. Res.
79, 670–679.
Kukley, M., Capetillo-Zarate, E., and
Dietrich, D. (2007). Vesicular glu-
tamate release from axons in white
matter. Nat. Neurosci. 10, 311–320.
Frontiers in Endocrinology | Cellular Endocrinology May 2013 | Volume 4 | Article 54 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amaral et al. Oligodendrocyte metabolism
Kurz, G. M., Wiesinger, H., and Ham-
precht, B. (1993). Purification of
cytosolic malic enzyme from bovine
brain, generation of monoclonal
antibodies, and immunocytochemi-
cal localization of the enzyme in glial
cells of neural primary cultures. J.
Neurochem. 60, 1467–1474.
Lee, Y., Morrison, B. M., Li, Y.,
Lengacher, S., Farah, M. H., Hoff-
man, P. N., et al. (2012). Oligoden-
droglia metabolically support axons
and contribute to neurodegenera-
tion. Nature 487, 443–448.
Madhavarao, C. N., Moffett, J. R.,
Moore, R. A., Viola, R. E., Nam-
boodiri, M. A., and Jacobowitz, D.
M. (2004). Immunohistochemical
localization of aspartoacylase in the
rat central nervous system. J. Comp.
Neurol. 472, 318–329.
Martinez-Hernandez, A., Bell, K. P., and
Norenberg, M. D. (1977). Gluta-
mine synthetase: glial localization in
brain. Science 195, 1356–1358.
McKenna, M., Gruetter, R., Sonner-
wald, U., Waagepetersen, H. S.,
and Schousboe, A. (2011). “Energy
metabolism of the brain,” in Basic
Neurochemistry: Principles of Mole-
cular, Cellular, and Medical Neuro-
biology, 8th Edn, eds S. T. Brady,
G. J. Siegel, R. W. Albers, and D. L.
Price (New York: Elsevier Academic
Press).
McKenna, M. C., Stevenson, J. H.,
Huang, X., Tildon, J. T., Zielke,
C. L., and Hopkins, I. B. (2000).
Mitochondrial malic enzyme activ-
ity is much higher in mitochon-
dria from cortical synaptic termi-
nals compared with mitochondria
from primary cultures of cortical
neurons or cerebellar granule cells.
Neurochem. Int. 36, 451–459.
McKenna, M. C., Tildon, J. T., Steven-
son, J. H., Huang, X., and King-
well, K. G. (1995). Regulation of
mitochondrial and cytosolic malic
enzymes from cultured rat brain
astrocytes. Neurochem. Res. 20,
1491–1501.
McKenna, M. C., Waagepetersen, H.
S., Schousboe, A., and Sonnewald,
U. (2006). Neuronal and astrocytic
shuttle mechanisms for cytosolic-
mitochondrial transfer of reduc-
ing equivalents: current evidence
and pharmacological tools.Biochem.
Pharmacol. 71, 399–407.
Meisingset, T. W., Ricca, A., Neri,
M., Sonnewald, U., and Gritti, A.
(2013). Region- and age-dependent
alterations of glial-neuronal meta-
bolic interactions correlate with
CNS pathology in a mouse model
of Globoid Cell Leukodystro-
phy. J. Cereb. Blood Flow Metab.
doi:10.1038/jcbfm.2013.64. [Epub
ahead of print].
Moffett, J. R., Ross, B., Arun, P., Mad-
havarao, C. N., and Namboodiri,
A. M. (2007). N-acetylaspartate in
the CNS: from neurodiagnostics to
neurobiology. Prog. Neurobiol. 81,
89–131.
Morland, C., Henjum, S., Iversen, E. G.,
Skrede, K. K., and Hassel, B. (2007).
Evidence for a higher glycolytic than
oxidative metabolic activity in white
matter of rat brain. Neurochem. Int.
50, 703–709.
Murin, R., Cesar, M., Kowtharapu, B.
S., Verleysdonk, S., and Hamprecht,
B. (2009). Expression of pyruvate
carboxylase in cultured oligoden-
droglial, microglial and ependymal
cells. Neurochem. Res. 34, 480–489.
Norenberg, M. D., and Martinez-
Hernandez, A. (1979). Fine struc-
tural localization of glutamine syn-
thetase in astrocytes of rat brain.
Brain Res. 161, 303–310.
Patel, M. S. (1974a). The effect of
ketone bodies on pyruvate carboxy-
lation by rat brain mitochondria. J.
Neurochem. 23, 865–867.
Patel, M. S. (1974b). The relative sig-
nificance of CO2-fixing enzymes in
the metabolism of rat brain. J. Neu-
rochem. 22, 717–724.
Pilkington, G. J., and Lantos, P. L.
(1982). The role of glutamine syn-
thetase in the diagnosis of cerebral
tumours. Neuropathol. Appl. Neuro-
biol. 8, 227–236.
Reubi, J. C., Van Der Berg, C., and
Cuenod, M. (1978). Glutamine as
precursor for the GABA and glu-
tamate transmitter pools. Neurosci.
Lett. 10, 171–174.
Richter, K., Hamprecht, B., and Sche-
ich, H. (1996). Ultrastructural local-
ization of glycogen phosphorylase
predominantly in astrocytes of the
gerbil brain. Glia 17, 263–273.
Rinholm, J. E., Hamilton, N. B., Kessaris,
N., Richardson, W. D., Bergersen, L.
H., and Attwell, D. (2011). Regu-
lation of oligodendrocyte develop-
ment and myelination by glucose
and lactate. J. Neurosci. 31, 538–548.
Shank, R. P., Bennett, G. S., Freytag,
S. O., and Campbell, G. L. (1985).
Pyruvate carboxylase: an astrocyte-
specific enzyme implicated in the
replenishment of amino acid neu-
rotransmitter pools. Brain Res. 329,
364–367.
Sickmann, H. M., Waagepetersen, H.
S., Schousboe, A., Benie, A. J., and
Bouman, S. D. (2012). Brain glyco-
gen and its role in supporting glu-
tamate and GABA homeostasis in
a type 2 diabetes rat model. Neu-
rochem. Int. 60, 267–275.
Snyder, C. D., and Wilson, J. E. (1983).
Relative levels of hexokinase in
isolated neuronal, astrocytic, and
oligodendroglial fractions from rat
brain. J. Neurochem. 40, 1178–1181.
Sokoloff, L. (1977). Relation between
physiological function and energy
metabolism in the central nervous
system. J. Neurochem. 29, 13–26.
Sonnewald, U., Westergaard, N.,
Schousboe, A., Svendsen, J. S.,
Unsgard, G., and Petersen, S. B.
(1993). Direct demonstration by
[13C]NMR spectroscopy that gluta-
mine from astrocytes is a precursor
for GABA synthesis in neurons.
Neurochem. Int. 22, 19–29.
Suzuki, A., Stern, S. A., Bozdagi, O.,
Huntley, G. W., Walker, R. H., Mag-
istretti, P. J., et al. (2011). Astrocyte-
neuron lactate transport is required
for long-term memory formation.
Cell 144, 810–823.
Sykes, J. E., Lopes-Cardozo, M., and Van
Den Bergh, S. G. (1986). Relation-
ship between the pentose-phosphate
pathway and the de novo synthe-
sis of fatty acids and cholesterol in
oligodendrocyte-enriched glial cul-
tures. Neurochem. Int. 8, 77–82.
van den Berg, C. J., and Garfinkel,
D. (1971). A stimulation study of
brain compartments. Metabolism of
glutamate and related substances
in mouse brain. Biochem. J. 123,
211–218.
Vogel, R., Hamprecht, B., and Wiesinger,
H. (1998a). Malic enzyme isoforms
in astrocytes: comparative study
on activities in rat brain tissue
and astroglia-rich primary cultures.
Neurosci. Lett. 247, 123–126.
Vogel, R., Jennemann, G., Seitz, J.,
Wiesinger, H., and Hamprecht,
B. (1998b). Mitochondrial malic
enzyme: purification from bovine
brain, generation of an antiserum,
and immunocytochemical localiza-
tion in neurons of rat brain. J. Neu-
rochem. 71, 844–852.
Waagepetersen, H. S., Sonnewald, U.,
Larsson, O. M., and Schousboe,
A. (2001). Multiple compartments
with different metabolic character-
istics are involved in biosynthesis of
intracellular and released glutamine
and citrate in astrocytes. Glia 35,
246–252.
Wallace, J. C., Jitrapakdee, S., and
Chapman-Smith, A. (1998). Pyru-
vate carboxylase. Int. J. Biochem. Cell
Biol. 30, 1–5.
Westergaard, N., Drejer, J., Schous-
boe, A., and Sonnewald, U. (1996).
Evaluation of the importance of
transamination versus deamination
in astrocytic metabolism of [U-
13C]glutamate. Glia 17, 160–168.
Xu, J., Song, D., Xue, Z., Gu, L., Hertz,
L., and Peng, L. (2013). Require-
ment of glycogenolysis for uptake of
increased extracellular K+ in astro-
cytes: potential implications for K+
homeostasis and glycogen usage in
brain. Neurochem. Res. 38, 472–485.
Yu, A. C., Drejer, J., Hertz, L., and
Schousboe, A. (1983). Pyruvate car-
boxylase activity in primary cul-
tures of astrocytes and neurons. J.
Neurochem. 41, 1484–1487.
Ziskin, J. L., Nishiyama, A., Rubio,
M., Fukaya, M., and Bergles, D.
E. (2007). Vesicular release of glu-
tamate from unmyelinated axons
in white matter. Nat. Neurosci. 10,
321–330.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 12 March 2013; accepted: 24
April 2013; published online: 13 May
2013.
Citation: Amaral AI, Meisingset
TW, Kotter MR and Sonnewald
U (2013) Metabolic aspects of
Neuron-Oligodendrocyte-Astrocyte
interactions. Front. Endocrinol. 4:54. doi:
10.3389/fendo.2013.00054
This article was submitted to Frontiers
in Cellular Endocrinology, a specialty of
Frontiers in Endocrinology.
Copyright © 2013 Amaral, Meisingset ,
Kotter and Sonnewald. This is an open-
access article distributed under the terms
of the Creative Commons Attribution
License, which permits use, distribution
and reproduction in other forums, pro-
vided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
www.frontiersin.org May 2013 | Volume 4 | Article 54 | 5
